In COVID-19 clinical update #78, Daniel Griffin covers ivermectin, convalescent plasma, disease in pregnant women, children and COVID, delta outbreak in an elementary school, validation of at-home antigen test, shedding in infected vaccinated people, mRNA vaccine antibody responses compared, AZD7442, fluvoxamine, one year outcomes in hospitalized patients, and post-vaccination disease.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Do not take veterinary ivermectin (FDA)
• Ivermectin side effects (CDC)
• Do not use convalescent plasma (IDSA)
• COVID-19 in pregnant women (JAMA)
• Children and COVID-19 data (AAP)
• Long COVID in 11-17 year olds (Res Square)
• Delta outbreak elementary school (MMWR)
• Validation of at-home antigen test (JAMA)
• Shedding in infected vaccinated people (medRxiv)
• Compared antibody responses after mRNA vaccination
• (JAMA)
• AZD7442 PROVENT phase III (AZ)
• Fluvoxamine trial (medRxiv)
• One-year outcomes hospital survivors (Lancet)
• Post-vaccination illness (Lancet)
• Letters read on TWiV 800
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]